Icatibant 46708-0654
Product NDC
46708-0654- Manufacturer
- Alembic Pharmaceuticals Limited
- Dosage Form
- Injection
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 14, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA213773
Need to source Icatibant? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Icatibant Acetate | 30 mg/3mL |
Drug Class
Bradykinin B2 Receptor Antagonist [EPC]Bradykinin B2 Receptor Antagonists [MoA]
Packaging Options(2)
1 SYRINGE, GLASS in 1 CARTON (46708-654-03) / 3 mL in 1 SYRINGE, GLASS
3 SYRINGE, GLASS in 1 CARTON (46708-654-09) / 3 mL in 1 SYRINGE, GLASS